Diabetes Darrow Flashcards

(43 cards)

1
Q

granuloma annulare

A

type IV rxn

associated with diabetes, thyroid disease, infection, malignancy, drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

metabolic syndrome

A

2 physical findings
-waist circumference and HTN

3 lab findings
-triglycerides, HDL-C, and glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

apple

A

bad body shape

-want to be a pear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adipose tissue

A

secretes inflammatory and immune mediators

-adipokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

abdominal fat

A

vs. subQ

causal factor mediating insulin resistance, increased diabetes risk, and cardiovascular disease in metabolic syndrome

dysregulated adipokine secretion, FFA toxicity, macrophage infiltration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

obese inflamed fat

A

release of adipokines

low levels of adiponectin

has lots of macrophages

with obesity and insulin resistance

this can promote ectopic lipid accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

lean person adipose tissue

A

few macrophages, high adiponectin, low inflammatory cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TZD

A

thiazolinediones

activate PPAR

cause insulin resistance, VEGF angiogenesis inhibiton, increased leptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TSP1

A

to TGF-beta
to PAI-1 (procoagulant)
to atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

with metabolic syndrome

A
hyperuricemia
larger hyperdense LDL
increased PAI - atherosclerosis
increased platelet adhesion
decreased homocysteine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

diagnosis of type II DM

A

random >200 with sx

FBS >126 x2 (pre 100-125)

post meal >200 x2 (pre 140-199)

HBA1C >6.5% x2 (pre 5.7-6.4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

causes of DM II

A

genetic - beta cell fatigue and death
-TCF7L2 - transcription factor in beta cell development

environmental - visceral obesity - insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TCF7L2

A

genetic mutation in DM II

Wnt signaling pathway - for beta cell development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

vitiligo in DM I?

A

autoimmune - so see mix of sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

polyuria

A

C-DRIPPED

cortisol excess
DM
recovery from renal failure
ions (hyper Ca, hypo K)
parkinsons - nocturnal nocturia
psychogenic polydipsia
enzyme
drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Abs in DM I

A
GAD 65
insulin Abs
islet cell cytoplasmic Abs
insulinoma associated 2
zinc transporter Abs
tyrosine phosphatase Abs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

HLA in DM I

A

DR3 and DR4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MODY

A

maturity onset diabetes of youth

defect in TFHNF1
-results in decreased apoM**

decreased clearance of HDL

19
Q

acanthosis nigricans

A

sign of insulin resistance

-DM II

20
Q

TFHNF1

A

with MODY

no apoM - so HDL is high

21
Q

most common MODY

A

type 3

do respond to sulfonylureas

22
Q

MODY syndromes

A

involve impaired glucose induced secretion of insulin

23
Q

high E and NE

A

decrease insulin secretion

  • due to alpha2 adrenergic activation
  • result in hyperglycemia
24
Q

cause of insulin resistance

A

obesity and hyperglycemia

all proteins get glycated

25
drugs causing hyperglycemia
``` beta blockers glucocorticoids antipsychotic - olanzapine statins oral contraceptives pentamidine cyclosporine niacin ```
26
TNF alpha
blocks effects of insulin -muscle, liver, fat problem of obesity in DM II
27
muscle insulin resistance
excess calories - lipogenesis with excess malonyl CoA - blockage of fatty acyl CoA oxiation byproducts - DAG and ceramide ceramide activates PKC pathways - inhibit insulin receptor activity
28
eruptive xanthoma
hepatic overproduction of VLDL (type 4) associated with diabetes
29
cheiropathy
limited joint mobility can't prayer sign hands with diabetes
30
coronary artery disease equivalents
DM cerebral arterial disease aortic aneurysm PVD
31
most diabetics
on statins - coronary artery disease equivalent
32
type IIb hyperlipidemia
increased heaptic secretion of apoB100 and VLDL no xanthomas
33
hypoglycemia
insulinoma
34
whipples triad
insulinoma if: 1 signs and sx of hypoglycemia 2 low glucose at time of event (<50) 3 reversal with correction of hypoglycemia
35
sympathoadrenal signs
glucose <60 sweating, tachycardia, tachypnea, anxiety, tremors, nausea more with post-prandial
36
neuroglycopenic signs
glucose <50 blurry vision, fatigue, dizzy, HA, seizure, confused, coma, death more with fasting
37
diagnosis of insulinoma
72 hour fast with insulin and glucose measure
38
insulinomas
80% are benign pancreatic adenoma tx - surgery
39
diazoxide
opens K channels - to stop insulin secretion in insulinoma
40
in hypoglycemia
should see low glucose and low insulin
41
C-peptide present in hypoglycemia
taken sulfonylurea drug**
42
C peptide absent
taken too much insulin**
43
nesidioblastoma
noninsulinoma pancreatogenous hypoglycemia syndrome pancreatic cell hyperplasia post prandial hypoglycemia